Piramal Pharma Ltd Quarterly Results

Gross Sales

2,043.72

1,933.71

2,754.07

2,204.22

2,241.75

Excise Duty

0

0

0

0

0

Net Sales

2,043.72

1,933.71

2,754.07

2,204.22

2,241.75

Other Operating Income

0

0

0

0

0

Other Income

80.39

97.71

58.25

29.18

78.37

Total Income

2,124.11

2,031.42

2,812.32

2,233.4

2,320.12

Total Expenditure

1,885.03

1,827.01

2,193.08

1,866.48

1,900.14

PBIDT

239.08

204.41

619.24

366.92

419.98

Interest

82.42

86.15

103.68

103.31

107.64

PBDT

156.66

118.26

515.56

263.61

312.34

Depreciation

202.84

197.28

242.76

196.81

192.22

Minority Interest Before NP

0

0

0

0

0

Tax

55.34

34.22

93.81

71.98

94.27

Deferred Tax

-2.3

-31.54

25.49

-8.86

3.26

Reported Profit After Tax

-99.22

-81.7

153.5

3.68

22.59

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-99.22

-81.7

153.5

3.68

22.59

Extra-ordinary Items

0

11.76

0

0

0

Adjusted Profit After Extra-ordinary item

-99.22

-93.46

153.5

3.68

22.59

EPS (Unit Curr.)

-0.75

-0.62

1.16

0.03

0.17

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

1,325.52

1,324.82

1,324.35

1,323.58

1,323.14

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

11.69

10.57

22.48

16.64

18.73

PBDTM(%)

7.66

6.11

18.71

11.95

13.93

PATM(%)

-4.85

-4.22

5.57

0.16

1